Which analyst expects BELLUS Health Inc. (BLU) to perform well in the near future?

As of close of business last night, BELLUS Health Inc.’s stock clocked out at $7.50, down -1.19% from its previous closing price of $7.59. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 614068 shares were traded. BLU stock price reached its highest trading level at $7.70 during the session, while it also had its lowest trading level at $7.40.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".

Sponsored

Ratios:

To gain a deeper understanding of BLU’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.00 and its Current Ratio is at 17.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on July 29, 2021, initiated with a Buy rating and assigned the stock a target price of $9.

On January 29, 2021, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $8.

On November 18, 2020, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $12.Evercore ISI initiated its Outperform rating on November 18, 2020, with a $12 target price.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 59278.12 while its Price-to-Book (P/B) ratio in mrq is 2.25.

Stock Price History:

Over the past 52 weeks, BLU has reached a high of $12.69, while it has fallen to a 52-week low of $5.72. The 50-Day Moving Average of the stock is 7.83, while the 200-Day Moving Average is calculated to be 9.25.

Shares Statistics:

It appears that BLU traded 624.19K shares on average per day over the past three months and 569.87k shares per day over the past ten days. A total of 121.80M shares are outstanding, with a floating share count of 103.38M. Insiders hold about 3.30% of the company’s shares, while institutions hold 89.17% stake in the company. Shares short for BLU as of Jan 30, 2023 were 8.91M with a Short Ratio of 9.44M, compared to 10.33M on Dec 29, 2022.

Earnings Estimates

As of right now, 4 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.19 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.26, while EPS last year was -$0.18. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.04 and low estimates of -$0.27.

Analysts are recommending an EPS of between -$0.56 and -$0.78 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.78, with 4 analysts recommending between -$0.18 and -$1.12.